Gamaleya Research Institute of Epidemiology
COVID-19 Vaccines: Moderna declares successful trial results after Pfizer
The new vaccine candidate by Moderna Inc, called mRNA-1273, has reportedly shown 94.5% efficacy against the SARS-CoV-2 in the phase III clinical trials
Even with vaccines, it is a long and rocky road to immunity
Even if the major economies can solve their own problems of procuring the vaccines by jumping the queue with money or captive production capacities, what about the rest of the world?
- “Why aren’t you at The Hague?”: Journalist dragged from US Secretary of State briefing
- Warhawk Senator Marco Rubio confirmed as Trump’s Secretary of State
- Impeached South Korean president Yoon Suk Yeol arrested over martial law decree
- Guatemalan journalist José Rubén Zamora to remain under house arrest
- Former Colombian president calls for a military invasion of Venezuela
